forpolicymakers
germanycountry
Go back to Germany page
Primary purpose: To analyze and provide an overview of the utilization of cancer early detection services offered by the German statutory health insurance (GKV).
Sponsor, manager or home institution: Wissenschaftliches Institut der AOK (WIdO).
Type of information: The report outlines cancer screening services covered by the German statutory health insurance (GKV), including screenings for cervical, prostate, colorectal, breast, and skin cancers, as well as general health checks and screening for abdominal aortic aneurysms. It tracks usage rates of these screenings from 2019 to 2022, noting the impact of the COVID-19 pandemic on participation. A key focus is colorectal cancer screening, analyzing trends in colonoscopy usage for diagnostic and preventive purposes. The report also discusses changes in cancer mortality and cancer incidence in Germany, highlighting declines in certain cancers due to early detection. Additionally, it addresses challenges like false positives and examines regional differences in screening uptake. Click here to learn more.
Data level: national level.
Cancer areas of interest: C15-C26: Digestive system cancers, C43-C44: Skin cancers/melanoma, C50: Breast cancer, C51-C58: Female genitalia cancer, C60-C63: Male genitalia cancer. Click here to learn more.
Access to information: Click here to access.
Esophagus
Stomach
Small intestine
Large intestine
Rectum
Anus
Liver
Gallbladder
Bile ducts
Pancreas
Colon
Skin
Melanoma
Scalp
Lips
Hands
Feet
Lobular
Vulva
Prostate
Breast
Vagina
Testicles
Nipple
Cervix
Penis
Areola
Uterus
Ductal
Ovary
Fallopian tubes
Endometrium
dataOwner::Wissenschaftliches Institut der AOK (WIdO)
availableVariable::screening
availableVariable::diagnosis|cervical
availableVariable::medical procedures|preventive
availableVariable::number of deaths|cancer mortality
availableVariable::cancer incidence
availableVariable::check-up examinations|false positives
dataLevel::national level
hasCancerType::C15-C26: Digestive system cancers
hasCancerType::C43-C44: Skin cancers/melanoma
hasCancerType::C50: Breast cancer
hasCancerType::C51-C58: Female genitalia cancer
hasCancerType::C60-C63: Male genitalia cancer
isReport
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C97: All cancer types
hasCancerType::C00-C14: Mouth/throat cancers
hasCancerType::C30-C39: Lung/chest cancers
hasCancerType::C40-C41: Bone cancers
hasCancerType::C45-C49: Soft tissue cancer
hasCancerType::C51-C58: Female genitalia cancers
hasCancerType::C64-C68: Urinary system cancers
hasCancerType::C69-C72: Eye and brain cancer
hasCancerType::C73-C75: Thyroid and other gland cancers
hasCancerType::C76-C80: Cancers of unknown or unspecified areas
hasCancerType::C81-C96: Cancers of the blood and immune system
hasCancerType::C97-C97: Cancers in multiple locations from the start
hasCancerType::D00-D09: Early-stage cancers not yet spread
hasCancerType::D10-D36: Benign tumour
hasCancerType::D37-D48: Growths of uncertain nature
hasCancerType::unknown
